Practice
Featured experience
MSG Networks comprehensive out-of-court debt restructuring
We advised the administrative agent and a lender on the transaction
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Deutsche Bank $1.75 billion notes offerings
The offerings included fixed-to-floating-rate and floating-rate eligible liabilities notes
UBS $1.25 billion senior notes offering
The investment-grade notes are due 2028
BBVA $1 billion preferred securities offering
We advised BBVA on its offering of contingent convertible perpetual preferred securities
Toyota Motor Credit $2.6 billion notes offering
We advised Toyota Motor Credit on the SEC-registered notes offering
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
CRH $3 billion guaranteed notes offering
The investment-grade notes are due 2030, 2035 and 2055
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
BrainAurora Medical Technology HK$583 million IPO
We advised BrainAurora on its IPO and HKEX listing
Veritas Technologies comprehensive debt recapitalization transaction
We advised an ad hoc group of term lenders and noteholders on the transaction